TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Immunodiagnostics Market – By Product
1.3.2 North America Immunodiagnostics Market – By Clinical Indication
1.3.3 North America Immunodiagnostics Market – By End User
1.3.4 North America Immunodiagnostics Market– By Country
2. North America Immunodiagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Immunodiagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Increasing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus On R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in The Field of Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market– North America Analysis
6.1 North America Immunodiagnostics Market Revenue Forecast and Analysis
6.1.1 Company Analysis
6.2 Comparative Company Analysis
6.2.1 Market Share Analysis (2021)
6.2.2 Growth Strategy Analysis
6.2.3 Market Positioning of Key Players in Immunodiagnostics Market
6.2.3.1 Abbott
6.2.3.2 F. Hoffmann-La Roche Ltd
7. Immunodiagnostics Market Analysis and Forecasts To 2028 – By Product
7.1 Overview
7.2 North America Immunodiagnostics Market, By Product 2021 & 2028 (%)
7.3 Enzyme-Linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-Linked Immunosorbent Assays (ELISA) Market Revenue and Forecast to 2028 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA) Market Revenue and Forecast to 2028 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay Market Revenue and Forecast to 2028 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection Market Revenue and Forecast to 2028 (US$ Million)
7.4.5 HIV Ag/Ab Combo Assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay Market Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA) Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. Immunodiagnostics Market Analysis and Forecasts To 2028 – By Clinical Indication
8.1 Overview
8.2 North America Immunodiagnostics Market, By Clinical Indication 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 COVID-19
8.3.3.1 Overview
8.3.3.2 COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Lyme
8.3.4.1 Overview
8.3.4.2 Lyme Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Zika
8.3.5.1 Overview
8.3.5.2 Zika Market Revenue and Forecast to 2028 (US$ Million)
8.3.6 Infection Management
8.3.6.1 Overview
8.3.6.2 Infection Management Market Revenue and Forecast to 2028 (US$ Million)
8.3.7 TORCH
8.3.7.1 Overview
8.3.7.2 TORCH Market Revenue and Forecast to 2028 (US$ Million)
8.3.8 Tuberculosis
8.3.8.1 Overview
8.3.8.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
8.3.9 Treponema
8.3.9.1 Overview
8.3.9.2 Treponema Market Revenue and Forecast to 2028 (US$ Million)
8.3.10 Measles and Mumps
8.3.10.1 Overview
8.3.10.2 Measles and Mumps Market Revenue and Forecast to 2028 (US$ Million)
8.3.11 EBV
8.3.11.1 Overview
8.3.11.2 EBV Market Revenue and Forecast to 2028 (US$ Million)
8.3.12 VZV
8.3.12.1 Overview
8.3.12.2 VZV Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hepatitis+HIV
8.4.1 Overview
8.4.2 Hepatitis+HIV Market Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal Market Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolics
8.6.1 Overview
8.6.2 Metabolics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension Market Revenue and Forecast to 2028 (US$ Million)
8.7.4 GROWTH
8.7.4.1 Overview
8.7.4.2 GROWTH Market Revenue and Forecast to 2028 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid Market Revenue and Forecast to 2028 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology Market Revenue and Forecast to 2028 (US$ Million)
9. Immunodiagnostics Market Analysis and Forecasts To 2028 – By End User
9.1 Overview
9.2 North America Immunodiagnostics Market, By End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostics Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories Market Revenue and Forecast to 2028 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. North America Immunodiagnostics Market – Country Analysis
10.1 North America: Immunodiagnostics Market
10.1.1 Overview
10.1.2 North America: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2.1 US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.1 US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.2 US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2.1 Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.1 Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.2 Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2.1 Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.1 Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.2 Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. North America: Impact Assessment of COVID-19 Pandemic
12. Immunodiagnostics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Immunodiagnostics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DiaSorin S.p.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens Healthineers AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 SWOT Analysis
13.6.5 Key Developments
13.7 PerkinElmer Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 bioMerieux SA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Infectious Diseases and Funding
Table 2. North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 7. North America Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 8. US Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 9. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)
Table 10. US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 12. US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 13. US Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 16. Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 17. Canada Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 19. Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)
Table 25. Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. Organic Developments in the Immunodiagnostics Market
Table 27. Inorganic Developments in the Immunodiagnostics Market
Table 28. Glossary of Terms, Immunodiagnostic Market